Literature DB >> 26026699

A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.

Artak Tovmasyan1, Clarissa G C Maia2, Tin Weitner1, Sebastián Carballal3, Romulo S Sampaio2, Dominik Lieb4, Robert Ghazaryan5, Ivana Ivanovic-Burmazovic4, Gerardo Ferrer-Sueta6, Rafael Radi3, Julio S Reboucas7, Ivan Spasojevic8, Ludmil Benov9, Ines Batinic-Haberle10.   

Abstract

Because of the increased insight into the biological role of hydrogen peroxide (H2O2) under physiological and pathological conditions and the role it presumably plays in the action of natural and synthetic redox-active drugs, there is a need to accurately define the type and magnitude of reactions that may occur with this intriguing and key species of redoxome. Historically, and frequently incorrectly, the impact of catalase-like activity has been assigned to play a major role in the action of many redox-active drugs, mostly SOD mimics and peroxynitrite scavengers, and in particular MnTBAP(3-) and Mn salen derivatives. The advantage of one redox-active compound over another has often been assigned to the differences in catalase-like activity. Our studies provide substantial evidence that Mn(III) N-alkylpyridylporphyrins couple with H2O2 in actions other than catalase-related. Herein we have assessed the catalase-like activities of different classes of compounds: Mn porphyrins (MnPs), Fe porphyrins (FePs), Mn(III) salen (EUK-8), and Mn(II) cyclic polyamines (SOD-active M40403 and SOD-inactive M40404). Nitroxide (tempol), nitrone (NXY-059), ebselen, and MnCl2, which have not been reported as catalase mimics, were used as negative controls, while catalase enzyme was a positive control. The dismutation of H2O2 to O2 and H2O was followed via measuring oxygen evolved with a Clark oxygen electrode at 25°C. The catalase enzyme was found to have kcat(H2O2)=1.5×10(6)M(-1) s(-1). The yield of dismutation, i.e., the maximal amount of O2 evolved, was assessed also. The magnitude of the yield reflects an interplay between the kcat(H2O2) and the stability of compounds toward H2O2-driven oxidative degradation, and is thus an accurate measure of the efficacy of a catalyst. The kcat(H2O2) values for 12 cationic Mn(III) N-substituted (alkyl and alkoxyalkyl) pyridylporphyrin-based SOD mimics and Mn(III) N,N'-dialkylimidazolium porphyrin, MnTDE-2-ImP(5+), ranged from 23 to 88M(-1) s(-1). The analogous Fe(III) N-alkylpyridylporphyrins showed ~10-fold higher activity than the corresponding MnPs, but the values of kcat(H2O2) are still ~4 orders of magnitude lower than that of the enzyme. While the kcat(H2O2) values for Fe ethyl and n-octyl analogs were 803.5 and 368.4M(-1) s(-1), respectively, the FePs are more prone to H2O2-driven oxidative degradation, therefore allowing for similar yields in H2O2 dismutation as analogous MnPs. The kcat(H2O2) values are dependent on the electron deficiency of the metal site as it controls the peroxide binding in the first step of the dismutation process. SOD-like activities depend on electron deficiency of the metal site also, as it controls the first step of O2(●-) dismutation. In turn, the kcat(O2(●-)) parallels the kcat(H2O2). Therefore, the electron-rich anionic non-SOD mimic MnTBAP(3-) has essentially very low catalase-like activity, kcat(H2O2)=5.8M(-1) s(-1). The catalase-like activities of Mn(III) and Fe(III) porphyrins are at most, 0.0004 and 0.05% of the enzyme activity, respectively. The kcat(H2O2) values of 8.2 and 6.5M(-1) s(-1) were determined for electron-rich Mn(II) cyclic polyamine-based compounds, M40403 and M40404, respectively. The EUK-8, with modest SOD-like activity, has only slightly higher kcat(H2O2)=13.5M(-1) s(-1). The biological relevance of kcat(H2O2) of MnTE-2-PyP(5+), MnTDE-2-ImP(5+), MnTBAP(3-), FeTE-2-PyP(5+), M40403, M40404, and Mn salen was evaluated in wild-type and peroxidase/catalase-deficient E. coli.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26026699      PMCID: PMC4554972          DOI: 10.1016/j.freeradbiomed.2015.05.018

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  75 in total

1.  Reactions of manganese porphyrins and manganese-superoxide dismutase with peroxynitrite.

Authors:  Gerardo Ferrer-Sueta; Celia Quijano; Beatriz Alvarez; Rafael Radi
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  Manganese salen complexes with acid-base catalytic auxiliary: functional mimetics of catalase.

Authors:  Yukinobu Noritake; Naoki Umezawa; Nobuki Kato; Tsunehiko Higuchi
Journal:  Inorg Chem       Date:  2013-03-12       Impact factor: 5.165

3.  Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Authors:  Xiaodong Ye; Diane Fels; Artak Tovmasyan; Katherine M Aird; Casey Dedeugd; Jennifer L Allensworth; Ivan Kos; Won Park; Ivan Spasojevic; Gayathri R Devi; Mark W Dewhirst; Kam W Leong; Ines Batinic-Haberle
Journal:  Free Radic Res       Date:  2011-09-27

4.  A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity.

Authors:  Zrinka Rajic; Artak Tovmasyan; Ivan Spasojevic; Huaxin Sheng; Miaomiao Lu; Alice M Li; Edith B Gralla; David S Warner; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2012-02-13       Impact factor: 7.376

5.  A "push-pull" mechanism for heterolytic o-o bond cleavage in hydroperoxo manganese porphyrins.

Authors:  Ning Jin; Dorothée E Lahaye; John T Groves
Journal:  Inorg Chem       Date:  2010-11-16       Impact factor: 5.165

6.  Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants.

Authors:  G Ferrer-Sueta; I Batinić-Haberle; I Spasojević; I Fridovich; R Radi
Journal:  Chem Res Toxicol       Date:  1999-05       Impact factor: 3.739

7.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Michael M Ndengele; Vincenzo Mollace; Frank Porreca; Francesca Fabrizi; Emanuela Esposito; Emanuela Masini; George M Matuschak; Daniela Salvemini
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

Review 8.  Simple biological systems for assessing the activity of superoxide dismutase mimics.

Authors:  Artak Tovmasyan; Julio S Reboucas; Ludmil Benov
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

Review 9.  An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Redox Biol       Date:  2015-02-07       Impact factor: 11.799

Review 10.  Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators.

Authors:  Artak Tovmasyan; Huaxin Sheng; Tin Weitner; Amanda Arulpragasam; Miaomiao Lu; David S Warner; Zeljko Vujaskovic; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Med Princ Pract       Date:  2012-10-16       Impact factor: 1.927

View more
  19 in total

Review 1.  Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2018-08-28       Impact factor: 8.401

2.  Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate.

Authors:  Artak Tovmasyan; Jacqueline C Bueno-Janice; Melba C Jaramillo; Romulo S Sampaio; Julio S Reboucas; Natalia Kyui; Ludmil Benov; Brian Deng; Ting-Ting Huang; Margaret E Tome; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Antioxid Redox Signal       Date:  2018-03-27       Impact factor: 8.401

3.  Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.

Authors:  Yulyana Yulyana; Artak Tovmasyan; Ivy A W Ho; Kian Chuan Sia; Jennifer P Newman; Wai Hoe Ng; Chang Ming Guo; Kam Man Hui; Ines Batinic-Haberle; Paula Y P Lam
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

4.  Anticancer therapeutic potential of Mn porphyrin/ascorbate system.

Authors:  Artak Tovmasyan; Romulo S Sampaio; Mary-Keara Boss; Jacqueline C Bueno-Janice; Bader H Bader; Milini Thomas; Julio S Reboucas; Michael Orr; Joshua D Chandler; Young-Mi Go; Dean P Jones; Talaignair N Venkatraman; Sinisa Haberle; Natalia Kyui; Christopher D Lascola; Mark W Dewhirst; Ivan Spasojevic; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2015-10-20       Impact factor: 7.376

Review 5.  An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Redox Biol       Date:  2015-02-07       Impact factor: 11.799

6.  CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5.

Authors:  David Leu; Ivan Spasojevic; Huy Nguyen; Brian Deng; Artak Tovmasyan; Tin Weitner; Romulo S Sampaio; Ines Batinic-Haberle; Ting-Ting Huang
Journal:  Redox Biol       Date:  2017-04-22       Impact factor: 11.799

Review 7.  Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases.

Authors:  Mehdi Sharifi-Rad; Nanjangud V Anil Kumar; Paolo Zucca; Elena Maria Varoni; Luciana Dini; Elisa Panzarini; Jovana Rajkovic; Patrick Valere Tsouh Fokou; Elena Azzini; Ilaria Peluso; Abhay Prakash Mishra; Manisha Nigam; Youssef El Rayess; Marc El Beyrouthy; Letizia Polito; Marcello Iriti; Natália Martins; Miquel Martorell; Anca Oana Docea; William N Setzer; Daniela Calina; William C Cho; Javad Sharifi-Rad
Journal:  Front Physiol       Date:  2020-07-02       Impact factor: 4.566

8.  Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity.

Authors:  Shashank Shrishrimal; Arpita Chatterjee; Elizabeth A Kosmacek; Paul J Davis; J Tyson McDonald; Rebecca E Oberley-Deegan
Journal:  Free Radic Biol Med       Date:  2020-03-25       Impact factor: 7.376

Review 9.  Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future.

Authors:  Adam M Hirst; Fiona M Frame; Manit Arya; Norman J Maitland; Deborah O'Connell
Journal:  Tumour Biol       Date:  2016-02-18

10.  MnTnBuOE-2-PyP protects normal colorectal fibroblasts from radiation damage and simultaneously enhances radio/chemotherapeutic killing of colorectal cancer cells.

Authors:  Elizabeth A Kosmacek; Arpita Chatterjee; Qiang Tong; Chi Lin; Rebecca E Oberley-Deegan
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.